DEMANTNasdaq CopenhagenMedical DevicesIFRS · DKK

Demant A/S

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures, and sells hearing aids, hearing solutions, and related hearing care products and services. Through its group structure, it serves both professional hearing-care channels and end users across global markets.

Kysy yhtiöstä
Liikevaihto23,0mrd DKK
+2,5 %v/v
Liikevoitto (EBIT)3 832milj. DKK
−15,4 %v/v
EBIT-marginaali16,7%
−3,5 %-yks.v/v
Nettotulos1 544milj. DKK
−35,3 %v/v
Vapaa kassavirta3 200milj. DKK
−8,7 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

0510152025mrd DKK2020: 14,5 mrd DKK2020: EBIT 1,5 mrd DKK20202021: 18,4 mrd DKK2021: EBIT 3,4 mrd DKK20212022: 19,7 mrd DKK2022: EBIT 3,2 mrd DKK20222023: 22,4 mrd DKK2023: EBIT 4,1 mrd DKK20232024: 22,4 mrd DKK2024: EBIT 4,5 mrd DKK20242025: 23,0 mrd DKK2025: EBIT 3,8 mrd DKK202523,03,8
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Demant A/S

Liiketoiminta

Osuus liikevaihdosta
Hearing aids55 %

Core hearing devices sold through hearing-care channels and clinics.

Hearing care services20 %

Professional fitting, support, and aftercare linked to hearing aid use.

Audiology equipment15 %

Diagnostic and fitting equipment used by hearing-care professionals.

Hearing protection and communications10 %

Adjunct products for noise protection and workplace communication.

Asiakkaat

Demant sells primarily to hearing-care professionals, audiologists, clinics, and other channel partners that fit and dispense hearing solutions. It also reaches end users through hearing care services and related consumer-facing offerings, where fitting quality and long-term support are important purchase drivers.

Hearing-care professionals

Clinics, audiologists, and dispensers that buy hearing aids and fitting tools for patient care.

End users/patients

Individuals purchasing hearing solutions through professional channels or care services.

Diagnostic and hearing test providers

Customers that buy audiology equipment and workflow tools for testing and fitting.

Workplace and consumer protection buyers

Buyers of hearing protection and communication products for occupational or personal use.

Strategia

Demant's strategy is centered on broadening access to hearing healthcare through its product portfolio, service capabilities, and channel relationships. Competitive position depends on device quality, fitting outcomes, and the ability to serve professional hearing-care networks across multiple geographies.

Expand the hearing-care ecosystemKeskipitkä aikaväli

Combining devices, diagnostics, and services increases customer stickiness and channel relevance.

Deepen professional channel relationshipsLyhyt aikaväli

Clinics and audiologists influence product selection and patient outcomes.

Broaden geographic reachKeskipitkä aikaväli

Diversified market exposure helps balance country-specific reimbursement and demand patterns.

Maantiede

Demant operates internationally, with sales distributed across Europe, North America, and other global markets. Geography matters because hearing-care demand, reimbursement frameworks, and channel structures differ by country, shaping both product mix and go-to-market approach.

Riskit

Demant faces demand risk tied to hearing-care volumes, reimbursement conditions, and the pace at which patients seek treatment. It is also exposed to competitive pressure in premium hearing aids, product obsolescence, and channel dependence, since professional recommendations strongly influence sales.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Channel dependence1Reimbursement and market access changes2Competitive pricing and product substitution3Technology and innovation risk4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Channel dependenceVaikutus: KorkeaTodennäköisyys: Korkea

    Sales rely heavily on hearing-care professionals who influence product choice and adoption.

    Kohdistuu: Professional dispensing channels

  2. Reimbursement and market access changesVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Country-specific healthcare systems affect patient affordability and clinic demand.

    Kohdistuu: Europe and North America

  3. Competitive pricing and product substitutionVaikutus: KeskitasoTodennäköisyys: Korkea

    Hearing aids compete on technology, service, and brand, which can affect share.

    Kohdistuu: Core hearing solutions

  4. Technology and innovation riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    New digital features and fitting technologies can make existing products less competitive.

    Kohdistuu: Product portfolio

Kysy Clarifolta: Demant A/S

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Device sales, services, and channel deliveries may be recognized at different points in time.

Vaikutus: Can shift quarterly revenue and gross margin mix

Goodwill and intangible impairment

Acquired hearing-care businesses and brands require ongoing impairment assessment.

Vaikutus: Could create large non-cash charges if expectations weaken

Foreign exchange and hedging

International operations create transaction and translation exposure across currencies.

Vaikutus: May affect revenue, costs, and equity reserves

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Revenio Group Oyj

REG1V · Medical Devices

Nexstim Plc

NXTMH · Medical Devices

Bioretec Oy

BRETEC · Medical Devices

Modulight Oyj

MODU · Medical Devices

Arcoma

ARCOMA · Medical Devices

Braincool

BRAIN · Medical Devices

Päivitetty: 24.10.2026